On May 24, 2024, Caplin Point Laboratories Limited informed the stock exchanges that the company’s subsidiary, Caplin Steriles Limited, has received final approval from the United States Food and Drug Administration (USFDA). The approval is for its Abbreviated New Drug Application (ANDA) for Phenylephrine hydrochloride Ophthalmic Solution USP 2.5% and 10% (eye drops). Phenylephrine hydrochloride …


